Vitamin A found useful for more than vision loss

Article

Results from Age-Related Eye Disease Study have drawn attention to the role of nutritional supplementation in the management of eye disease.

Key Points

Houston-Results from the Age-Related Eye Disease Study have drawn attention to the role of nutritional supplementation in the management of eye disease. An evidence basis exists for its use in patients with retinitis pigmentosa, however. In addition, vitamin A deficiency should not be overlooked as an underlying cause of dry eye disease, said Jill Autry, OD, RPh.

Retinitis pigmentosa

Recommendations on the use of nutritional supplements for patients with retinitis pigmentosa (RP) are based on the results of prospective, randomized, controlled, parallel group studies where progression of retinal degeneration was monitored with electroretinography, visual field, and visual acuity testing.

"In a study evaluating nutritional supplementation for patients with RP, the annual rate of decline of visual field sensitivity loss was reduced by 40% to 50% among patients receiving vitamin A 15,000 IU/day compared with controls. This is a significant benefit considering the absence of any other treatments for RP," said Dr. Autry, adjunct faculty, University of Houston College of Optometry, and in private practice, Eye Center of Texas, Bellaire.

The recommendation for adding DHA for 2 years in patients who are just starting vitamin A supplementation is based on the results of a 4-year controlled clinical trial. In the overall study population, no significant difference was seen in the rate of retinal degeneration among patients receiving vitamin A palmitate plus DHA versus controls treated with vitamin A alone. Subgroup analyses found that among patients who had not previously used vitamin A, adding DHA slowed the course of RP progression during the first 2 years of the study. In addition, the subgroup analyses found that patients who had been using vitamin A for at least 2 years benefited with a slower decline in visual field sensitivity if they had a diet rich in omega-3 fatty acids.

"Based on the latter finding, RP patients who are not considered candidates for DHA supplementation may still be advised to obtain as much of this omega-3 fatty acid as they can in their diet through fish consumption," Dr. Autry said.

Vitamin A and dry eye

Vitamin A deficiency leading to severe ocular surface disease and scarring is a major cause of blindness among children living in developing countries where diet is poor. Even in the United States, patients occasionally may be encountered with ocular surface disease that is related to vitamin A deficiency. Several possible causes for vitamin A deficiency exist, Dr. Autry said.

"Primary vitamin A deficiency as a result of a poor diet does occur in this country among low income groups, abused children, or alcoholics. Vitamin A also may be lacking in certain stringent diets followed by vegetarians," she said.

"In addition, vitamin A deficiency can occur secondary to various malabsorption or storage conditions, including in persons with Crohn's disease, liver disease, pancreatic disease, or a history of intestinal or bariatric surgery," Dr. Autry added.

Severe xerosis and keratinization of both the cornea and conjunctiva should prompt consideration of the diagnosis of vitamin A deficiency, and it can be established by a simple blood test. Then, for correction of the vitamin A deficiency, patients should be referred to their primary medical doctor or other medical specialist who is providing care for their underlying condition. Patients with severe ocular surface disease also should be referred to a corneal specialist.

"Once vitamin A supplementation has been initiated, improvement in the condition of the ocular surface may be seen within days to weeks if there has not already been permanent scarring," Dr. Autry noted.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.